This is startlingly good news.....
Analysis showed 50% reduction in emphysema progression.
Regular aspirin use was associated with a more than 50% reduction in emphysema/chronic obstructive pulmonary disease (COPD) progression in an elderly cohort over a decade in a longitudinal analysis of data from a large lung study.
The association was seen across aspirin doses and was greatest in older study participants with significant airflow obstruction.
Results were similar in ever-smokers and for doses of 81 mg and 300-325 mg. A greater magnitude effect was seen among participants with airflow limitations.